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Objective: To exploit state variations in infant mortality over time, identify diagnoses that contributed to 
reduction of the infant mortality rate (IMR) between 2000 and 2015, and examine factors associated with 
preterm related deaths at the state level. 
Methods: Using linked birth-infant deaths period data files from 2000 to 2015, we examined patterns in 
the leading causes of infant deaths including (1) the preterm-related mortality rate (PMR), (2) the 
congenital malformation-related mortality rate (CMR), (3) the sudden infant death syndrome mortality rate 
(SMR), and (4) all other 130 major mortality causes (OMR). We compared these rates at both national 
and state levels in 2000 and 2015 to find reduction trends. Creating a cross-sectional time series of 
states’ PMR data and some explanatory variables, we implemented a fixed-effect regression model 
controlling for infant, maternal, and institutional characteristics. 
Results: We found substantial state-level variations in changes of the IMR (range= -2.87 to 2.08), PMR 
(range= -1.77 to 0.67) and the CMR (range= -1.23 to 0.59) between 2000 and 2015. Twenty-one states in 
which the IMR declined more than the national average of 0.99 (from 6.89 to 5.90) were labeled as 
successful. We also labeled 20 states that saw a decline in their IMR less than the national average as 
unsuccessful. In the successful states, we found a reduction in the PMR accounted for the largest decline 
in the IMR—0.90 fewer deaths per 1,000 live births—or six times more than the PMR decline (0.14) in 
unsuccessful states. Changes in the other subgroups did not differ significantly in successful and 
unsuccessful states. Regression results showed that the PMR is positively associated with inadequate 
care (P-Value <0.05). A one-percentage-point decline in the share of pregnant women with inadequate 
care is significantly associated with 0.011 fewer preterm-related deaths per 1,000 live births. The 
magnitude of this variable is small relative to the PMR mean. The percentage of teen pregnancies, 
multiple births, and pregnant women that smoke was not significantly associated with the state-level 
PMR. 
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Policy Implications: Trends in the leading causes of mortality reduction are heterogeneous across 
states. States with high infant mortality need to focus on preterm-related deaths, as they are the largest 
contributor to the success of states with a high infant-death reduction. Although its impact is not large, 
reducing the percentage of pregnant women with inadequate care is one of the mechanisms through 
which preterm-related deaths might decrease.  
Background 
The U.S. infant mortality rate (IMR) increased in 2015 after a decade of decline—from 2005 to 
2014 (1). The U.S. IMR is 71% higher than the average rate for comparable countries in the Organization 
for Economic Co-operation and Development (OECD) (2). Although the U.S. rate declined by 14%, from 
6.89 in 2000 to 5.90 in 2015, infant mortality has declined more slowly than in comparable countries. The 
IMR is defined as the number of infant deaths per 1,000 live births before their first birthday, and it is a 
representation of population health, quality of health care, and societal well-being (3). 
Preterm birth, one of the most complicated factors associated with infant mortality (4, 5), has 
become a focus of research. Despite the reduction in recent decades, preterm birth in the U.S. (9.8%) 
remains higher than in European countries such as France (7.5%), Germany (8.3%), and Sweden (5.8%) 
(6). States vary substantially in terms of IMR size, trends, and preterm-related mortality rate (PMR). 
Figure 1.a shows the rate of infant mortality for 50 states from 2000 to 2015. The size of each dot is 
proportionate to the number of births in corresponding states and years. The continuous line shows the 
national average at each year. Four observations can be inferred from Figure 1.a: (1) states differ 
considerably in their IMR each year, (2) the IMR in larger states tend to be closer to the average, (3) 
states experienced a diverse change in their IMR from 2000 to 2015, and (4) on average, states 
experienced a decline in their IMR. However, the rates in Maine, South Dakota, and Texas are all higher 
in 2015 than in 2000. States also vary in mortality rates for babies born preterm. Figure 1.b shows the 
changes in PMR between 2000 and 2015 for each state. States such as Tennessee and Michigan 
reduced the PMR by more than 1.2 deaths per 1,000 live births, while the PMR increased by more than 
0.5 deaths per 1,000 live births in Alaska, Maine, and South Dakota.  
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a.	Infant	mortality	for	each	state	from	2000	to	2015.	 b.	 PMR	 reductions:	 per	 1000	 live	 births,	 between	
2000	and	2015.	
 
Figure	1.	Trends	of	states’	infant	mortality	and	preterm-related	mortality	rates	from		2000-2015.1	
Note:	The	District	of	Columbia	was	dropped	since	the	large	change	is	attributed	to	demographic	changes	over	the	past	decade.	
 
The Centers for Disease Control and Prevention (CDC) reports national trends of infant mortality 
based on five leading causes that include: congenital malformations and chromosomal abnormalities, 
disorders related to short gestation and low birth weight, newborns affected by maternal complications of 
pregnancy, sudden infant death syndrome, and accidents. Change in state IMRs and variation across 
states have been reported from 2005 to 2014 (7), and infant mortality trends were also investigated in 
limited geographical locations. In five Southeastern states with the highest IMRs in the U.S., descriptive 
IMR statistics based on location, causes of death, infant and maternal characteristics were reported from 
2005 to 2009 (8).  Finally, a study of perinatal mortality in 50 states between 1989 and 2000 found that 
perinatal mortality among whites increased because of an increase in medically indicated preterm births 
(9). However, there are no studies comparing PMR trends by states over time. Many studies have 
focused on one state or a limited number of modifiable risk factors across states to investigate 
determinants of preterm births (9-13). 
Understanding drivers of IMR reduction in states that have achieved substantial rate reductions 
may help to improve high IMRs. In this study, we explore state variations of the IMR and categorize them 
                                                
1 Vermont is not shown because of data confidentiality. 
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as either successful—with an IMR reduction above the national average—or unsuccessful. We next 
examine the trends of four IMR subgroups—i.e., the PMR (preterm mortality rate): the CMR (congenital 
malformation-related mortality rate), the SMR (sudden mortality rate), and the OMR (other mortality 
rate)—in successful and unsuccessful states. Finally, we construct a cross-sectional time series data of 
the 50 states and run a fixed-effect model to examine the association between the PMR and explanatory 
variables. Specifically, our study aims to answer the following questions: (1) Which of the four IMR 
subgroup(s) are most responsible for the reduction of IMR at the national level from 2000 to 2015? 
(question 1); (2) Which subgroup(s) are most responsible for the IMR reduction in states that have 
successfully reduced their IMRs from 2000 to 2015? (question 2); and (3) Are variations in teen 
pregnancy, multiple birth, prenatal care, and multiple births associated with state variations in the PMR? 
(question 3). 
Method 
We obtained individual-level data from the linked birth-infant deaths period data files for the 
periods 2000 to 2015 (14) to compare states’ performance in reducing the infant mortality rate and find 
the factors that might be associated with the PMR. We divided the IMR into four main subgroups: the 
preterm-related mortality rate (PMR), the congenital malformations-related mortality rate (CMR), the 
sudden mortality rate (SMR), and other mortality rates (OMR) that includes all other causes of infant 
mortality. The first subgroup, PMR, is created based on Callaghan and colleagues’ criteria (15) and 
includes those with an underlying cause of death assigned to one of the following ICD-10 categories: 
K55.0, P010.0, P01.1, P01.5, P020, P02.0, P02.1, P02.7, P07, P10.2, P22, P27, P28.0, P28.1, P36, 
P52.0, P52.1, P52.2, P52.3, and P77. 
The ICD-10 code only considers “Disorders related to short gestation and low birth weight, not 
elsewhere classified (P07)” as PMR. Callaghan and colleagues showed that the ICD-10 criteria for 
assigning causes of death do not capture the true number of prematurity-related infant deaths. Callaghan 
and colleagues categorized preterm-related deaths as those that met two criteria: (1) a biological 
connection with preterm birth, and (2) more than 75% of infants for such a given cause are born preterm 
(15).  
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Congenital malformations, deformations, and chromosomal abnormalities (ICD10: Q00–Q99) are 
classified under the CMR as the second subgroup. The third subgroup, the SMR, includes infants that 
died due to sudden infant death (SID) syndrome (ICD10: R95). All other causes are classified as OMR 
(Appendix A provides a detailed list of the causes and their related ICD10 code). These four categories—
the PMR, CMR, SMR, and OMR—are mutually exclusive, which means that they should add up to the 
total IMR for each state and year. 
To identify the subgroup most responsible for the reduction of the IMR at the national level 
(question 1), we compared changes in the PMR, CMR, SMR, and OMR between 2000 and 2015. We 
calculated the percentage decline between 2000 and 2015 in each subgroup and compared the rates 
using the method described by Mathews and colleagues (16). 
To investigate the subgroup most responsible for the IMR reduction in states (question 2), we 
assigned 41 states to one of two groups: successful and unsuccessful. We chose the national IMR 
reduction size between 2000 and 2015 (i.e., 0.99) as the cutoff point. A state with a reduction size of 0.99 
or more was defined as “successful,” while all others were “unsuccessful.” We calculated the reduction in 
the PMR, CMR, SMR, and OMR for successful and unsuccessful states. We used a t-test to discern the 
statistical differences of mean-comparisons among states. To assess the appropriateness of using the 
pair-wised Student-t test, we used Bartlett’s test for homogeneity of variances to compare mean the 
mortality rates of successful and unsuccessful states. We dropped nine states for the following reasons. 
First, some states, such as Massachusetts, had a low IMR in 2000, and a minimal opportunity to improve 
such rate. However, other states, such as Mississippi, experienced a large reduction in their IMR (1.19, a 
drop from 10.64 to 9.45), but still remained the worst state in the U.S. in the overall rate of infant death in 
2015. Second, states in the two groups were not comparable because the mean IMR in 2000 was higher 
in successful states—7.53 versus 6.63. Nevertheless, we conducted the same analysis using the full 
sample of states and report the results in Appendix E . 
In addition, we constructed a state-level, cross-sectional time series data of 50 states from 2000 
to 2015 and used a fixed-effect, multiple linear regression analysis to investigate the association between 
the PMR and state-level explanatory variables (question 3). We accounted for serial correlation within 
states by clustering standard errors at the state level. The advantage of the fixed-effect model is that it 
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controls for unobserved factors that are constant over time. Some of the important predictors of birth 
outcome were unchanged between 2000 and 2015. For example, although the IMR is higher among 
African-American women, their birth rates did not change in every state from 2000 to 2015. Our model 
controlled for such factors that remained the same during the study period. We selected our explanatory 
variables based on evidence in the literature and availability of data in the linked birth-infant deaths period 
data files. These variables include teen pregnancy, multiple births at infant level, prenatal care, and 
tobacco use during pregnancy. 
Teen pregnancy is defined in each state as the percentage of mothers who were 19 or younger at 
the time of birth. Multiple births rate is a representation of live births for cases in which a mother delivered 
more than one baby in the same pregnancy. Tobacco use is the percentage of mothers who reported 
smoking at any time during pregnancy.  
Prenatal care variables indicates the percentage of women in each state who received care 
based on the Kessner Index (17). This method defines three levels for prenatal care: adequate, 
intermediate, and inadequate. Since these three variables are perfectly correlated, we dropped the 
adequate category, and we interpreted the results with respect to it. The linked birth-infant deaths period 
data reported on these variables until 2002. For the period after 2003, we constructed variables based on 
Kessner’s criteria presented in Appendix C . The Kessner Index has high predictive value for infant 
mortality and preterm birth (18, 19). 
The PMR is reported as deaths per 1,000 live births, and all explanatory variables are in 
percentages. Thus, to interpret the regression results, we examined how many deaths per 1,000 could be 
avoided if an explanatory variable is changed by one percentage point (e.g., how many deaths per 1,000 
live births would be avoided if we reduced teen pregnancy by one percentage point). Tobacco use and 
prenatal care were not available for some states between 2011 to 2015. We therefore ran two 
regressions. First, we regressed the PMR against teen pregnancy and multiple births using a cross-
sectional time series of 50 states from 2000 to 2015 that included 800 data points (i.e., 50 states over 16 
years). Second, the PMR and all explanatory variables were regressed in a data set of 46 states between 
2000 to 2010 (505 data points). The number of observations in the second regression analysis was 505, 
because some explanatory variables, such as tobacco use in California, is not available (see Appendix D  
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for a complete list of missing values). We also controlled for the effect of year by adding a continuous 
year variable. Calculations were performed on a Windows OS, using STATA/MP 14.0 software. 
Results 
Table 1 shows the national trends for the IMR values and its subgroups in the U.S. between 2000 
and 2015. The IMR declined from 6.89 to 5.90 between 2000 and 2015, representing about one fewer 
death per 1,000 live births. The preterm-related mortality rate (PMR) was the largest subgroup of IMR in 
2000, accounting for 2.46 deaths per 1,000 live births. The PMR subgroup was reduced to 2.07 deaths 
per 1,000 in 2015. In 2000, 1.41 deaths per 1,000 were caused by congenital malformations, which 
declined to 1.22 deaths per 1000 in 2015. The sudden mortality rate (SMR), the smallest subgroup of the 
IMR in 2000 and 2015, also declined from 0.62 to 0.39 deaths per 1,000, respectively. Other causes of 
deaths (OMR), the second largest subgroup, declined from 2.40 to 2.21 deaths per 1,000. The highest 
reduction, 0.39 deaths per 1,000 live births, occurred in the PMR subgroup. The percentage change in 
the SMR exceeded the other subgroups.  
Table	1	Summary	of	infant	mortality	rates 
Variable	 2000	 2015	 Reduction	Size	 Reduction	Rate	 P-Value	
IMR	 6.89	 5.90	 1.00	 14%	 <0.001	
PMR	 2.46	 2.07	 0.39	 16%	 <0.001	
CMR	 1.41	 1.22	 0.19	 14%	 <0.001	
SMR	 0.62	 0.39	 0.23	 36%	 <0.001	
OMR	 2.40	 2.21	 0.19	 8%	 <0.001	
 
Figure 2 depicts the subgroups’ trends in 2000 and 2015 for the two groups of successful and 
unsuccessful states. Successful states reduced their rates significantly in each of the subgroups (P-
value<0.05) while unsuccessful states only reduced their CMR significantly. When it came to comparing 
the difference in reduction sizes, the PMR was the only subgroup with a significantly different reduction in 
successful states versus unsuccessful. In other words, changes in the CMR, SMR, and OMR in 
successful states were not statistically different from changes in these subgroups in unsuccessful states.  
In 2000, the mean of the IMR in successful states was 7.08, and it significantly declined to 5.47 
(P-Value<0.001) in 2015, representing about 1.61 fewer deaths per 1,000 live births. The largest 
reduction is in the PMR in the successful states, a 0.90 reduction (P-Value <0.001), from 2.63 to 1.73. 
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The reduction size in the CMR, SMR, and OMR are all significant and equal to 0.22 (from 1.44 to 1.22 
with P-Value<0.001), 0.30 (from 0.63 to 0.33 with P-Value<0.001), and 0.18 (2.37 to 2.19 with P-
Value=0.022), respectively. Fifty-six percent of the IMR reduction (0.90 out of 1.61) in successful states 
was due to PMR reduction.  
In unsuccessful states, the IMR mean was 7.14 in 2000, which then declined by 0.65 (P-
Value<0.001) per 1,000 live births and reached 6.49. A decrease in PMR from 2.48 deaths per 1,000 to 
2.34—equivalent to a reduction size of 0.14— was not significant (P-Value=0.076). The CMR declined 
significantly by 0.27 from 1.53 to 1.26 (P-Value=0.003), the SMR reduced by 0.09 (P-Value=0.080) from 
0.65 to 0.56, and the OMR declined by 0.16 (P-Value=0.352) from 2.49 to 2.33 (Figure 2).  
The change in the PMR differed significantly between successful and unsuccessful states (P-
Value<0.001). Successful states reduced their PMRs by 0.90, while the other group experienced a slight 
decrease of 0.14 in their PMRs over the period of 2000 to 2015. The reduction for the CMR, SMR, and 
OMR was not significantly different (P-Values are 0.115, 0.137, 0.157 respectively) between the two 
groups of states. Successful states reduced their CMRs by 0.22, which is not significantly different (P-
Value= 0.115) than the reduction size in unsuccessful states—0.27. The SMR reduction size for 
successful states was 0.30, which is not significantly larger (P-Value=0.137) than the reduction size of 
unsuccessful states—0.09. The OMR reduction size was 0.18 in successful versus 0.16 in unsuccessful 
states, which was not significantly different (P-Value=0.157). Appendix F depicts the successful and 
unsuccessful states on the U.S. map. 
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Figure	2.	Performances	of	successful	and	unsuccessful	states	in	reduction	of	IMR	and	its	subgroups	in	2000	and	2015	in	selected	
states.		
In summary, our analyses showed that the largest reduction size occurred in the PMR subgroup 
at the national level. Further, states with an IMR reduction above the national average—successful 
states—experienced a much larger decline in the PMR subgroups during the period of 2000 to 2015. 
Successful states had a higher PMR in 2000 compared to unsuccessful states, and reduced it 
substantially by 2015, while other subgroup reductions were not significantly different between the two 
categories of states. In the next step, we examine the association between the PMR and some of the 
determinants of the PMR reported in the literature in a data set of 50 states from 2000 to 2015. 
Regression results for factors associated with PMR 
 
Table 2 shows the summary statistics of each PMR and explanatory variables for selected years 
of the study period. These covariates are not weighted based on population of states and cannot be 
interpreted as national estimates. Few states do not report tobacco use, adequate, intermediate, and 
inadequate care in some years (see Appendix D ). The first column shows the mean of each variable 
across the entire time frame. On average, 9.34% of pregnant women delivered their infant when they 
were teenagers, 3.35% of births were multiple births, 12.63% of pregnant women were tobacco users, 
68.95% received adequate care, 20.72% received intermediate care, and 9.39% received inadequate 
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care. The percentages of residents with different levels of care did not sum to 100% because of missing 
values between 2011 to 2015 in some states, such as Connecticut and New Jersey. 
Table	2	Summary	Data	on	Preterm-Related	Mortality	and	State-Level	Factors	for	50	U.S.	States	from	2000	to	2015	
Variable Mean (SD) Range  2000 2003 2006 2009 2012 2015 
PMR per 1000 Live 
Birth 
2.31 
(0.74) 0.52-5.02 2.46 2.50 2.40 2.25 2.16 2.06 
% of Teen 
Pregnancy 
9.34 
(2.98) 3.02-18.75 11.80 10.27 10.20 9.92 7.76 5.86 
% of Multiple Births 3.35 (0.44) 2.08-4.90 3.07 3.34 3.37 3.42 3.39 3.43 
% of Tobacco User 12.63 (5.04) 3.84-27.26 14.00 12.88 12.48 12.62 12.10 10.69 
% of Adequate 
Care 
68.95 
(8.76) 39.35-87.38 72.86 73.31 68.93 66.86 64.92 67.76 
% of Intermediate 
Care 
20.72 
(5.12) 9.13-46.95 18.08 17.98 18.31 22.11 23.76 21.50 
% of Inadequate 
Care 
9.39 
(5.62) 1.39-41.00 5.07 8.71 8.93 11.04 11.32 10.73 
Source: Linked Birth/ Infant Death Period Data, 2000-2015 
   Note 1: Data represented unweighted averages across states, and should not be interpreted as 
national estimates. 
Note 2: Tobacco Use, Adequate, Intermediate, and Inadequate Care have missing data points (see 
Appendix D ) 
 
Table 3 shows the results for the two fixed-effect models. The first regression investigates the 
association between the PMR and two explanatory variables—teen pregnancy and multiple births— from 
2000 to 2015 for 50 states, controlling for year effect and using the state-level fixed effect to control for 
differences between states. A one-percentage-point increase in the multiple birth rate is significantly 
associated with 0.18% more deaths per 1,000 live births. Teen pregnancy is not significant. The second 
regression reports the result when an institutional factor—prenatal care—and a maternal behavior 
characteristic—tobacco use—are added to the fixed-effect model. Since some states do not report 
tobacco use and prenatal care after 2010, the data set of the second regression include 46 states from 
2000 to 2010. In this regression, the only significant explanatory variable is “inadequate care”—the 
percentage of pregnant women who do not receive adequate care in a state. A one-percentage-point 
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decline in “inadequate care,” from 9.39% (mean reported in Table 2) to 8.39%, is associated with 0.011% 
less preterm-related deaths per 1,000 live births. The magnitude of this variable is not large relative to the 
state-level PMR mean (2.31).  
Table	3	Parameter	Estimates	for	Fixed-Effect	Regression	Models	of	the	Preterm-Related	Mortality	Rate	
Variables Regression 1 (n=800) Regression 2 (n=505) 
PMR Estimate P-Value Estimate P-Value 
% of Teen Pregnancy 0.009 0.653 0.002 0.966 
% of Multiple Births 0.182 0.021** 0.117 0.429 
% of Tobacco   -0.035 0.127 
% of Intermediate Care   0.007 0.315 
% of Inadequate Care   0.011 0.027** 
'**' Sig at 0.05 
Note: Data represented unweighted averages across states, and should not be interpreted as national 
estimates. 
Regression 1 is for 50 U.S. states from 2000 to 2015 and regression 2 is for 46 U.S. states from 2000 
to 2010. 
     
Discussion 
Despite the historic declines in the national infant mortality rate (IMR) during the past 16 years, 
significant variation in the reduction of infant mortality across states still exists. Some states have 
experienced an increase in their IMRs from 2000 to 2015. We categorized states into successful and 
unsuccessful groups based on their performance in reducing their IMRs and examined patterns in the 
leading causes of infant mortality across them. We found that decline in PMR was the major source of 
success in reducing the IMR during 2000-2015. A decline in the PMR accounts for 0.90 fewer deaths per 
1,000—an approximate 56% reduction in the IMR—in successful states.  
In addition, we found that preterm-related deaths fell more than other subgroups at the national 
level. The CDC listed congenital malformation as the first leading cause of infant death in the U.S. from 
2005 to 2014 (7) and in 2013 (16). The CDC report, as well as other reports on the IMR (10, 20, 21), only 
considered short gestation and low birth weight in calculating the PMR. Callaghan and colleagues 
demonstrated that this classification of infant death does not capture the true magnitude of 
preterm-related deaths (15). We therefore used the criteria reported by Callaghan and colleagues to 
identify preterm-related deaths. 
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Despite statewide variations in the reduction of IMR and PMR, we found a homogenous 
improvement in the sudden mortality rate (SMR) across states. National-level initiatives such as the “Safe 
Sleep Campaign,” which started in 1994, increased public awareness and led to lower rates of prone 
infant sleeping (22, 23). The rate of mortality related to sleeping dropped 36% on average in the U.S. 
between 2000 and 2015. Reduction of the other-related mortality rate (OMR) also did not differ in 
successful and unsuccessful states from 2000 to 2015. However, the decline in the OMR (8%) was 
substantially less than the 36% reduction seen in the SMR.  
Prenatal care may improve birth outcomes even in low income and resource settings (24-26). 
Prior studies have found that prenatal care is associated with reduced PMRs. Mothers who did not 
receive any prenatal care between 2005 and 2009 in Southeastern states, which have the highest rates 
of infant mortality and lowest average incomes, had the highest IMRs (8). Although we found a significant 
association between access to prenatal care and the PMR, the magnitude of the coefficient was small. 
We used a fixed-effect regression analysis to identify variables that might be associated with PMR 
variations across states. Our analysis revealed that a one-percentage-point decline in mothers that 
received inadequate care led to a decrease in preterm-related deaths of 0.011 per 1,000 live births. The 
magnitude of this variable relative to the mean PMR is not large, suggesting that an increase in prenatal 
care as currently practiced would not lead to a state-level reduction in the PMR. The small-effect size of 
prenatal care might also be due to a limitation of data collection or lack of control for other key 
explanatory variables such as adhering to prevention programs. 
Despite the emphasis on prenatal care, access to obstetric services is decreasing in the U.S. 
More than 9% of rural counties lost their obstetric services from 2004 to 2014, which made access to care 
harder for 28 million women of reproductive age (27). Our findings highlight the importance of eliminating 
an inadequacy of care. Models such as Coordinated Care Organizations significantly increase access to 
care with broad financing and delivery reforms that can reduce disparities in prenatal care and improve 
birth outcomes through a reduction in inadequate care (28). The adoption of expanded access to 
Medicaid has also been an effective policy. States that adopted Medicaid expansion have observed a 
reduction in their IMRs (29).  
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The risk factors, corresponding interventions, and causes of preterm mortality vary by target 
population. Iams and colleagues classified all possible interventions for a reduction of PMR risk factors 
into three main categories: primary (directed to all women), secondary (focusing on reducing existing 
risk), and tertiary (for improving preterm-infant outcomes) (30). Of these, the most improvement in the 
survival of preterm babies can be attributed to better neonatal care access (4). Obstetric interventions, 
such as antenatal corticosteroid treatment for women delivering preterm, also contribute to the decline in 
neonatal mortality.  
Another preconceptional strategy to decrease infant mortality is the adoption of steps to reduce 
the risk of higher-order gestation (4). We found that the percentage of women with multifetal pregnancies 
is significantly and positively associated with the PMR in the first regression in which we controlled for 
teen pregnancy. After adding prenatal care variables and tobacco use to our model, multifetal births still 
correlate positively with the PMR, but statistical significance is lost, perhaps for two reasons. First, the 
second regression has fewer observations (for 46 states from 2000 to 2010) than the first regression (50 
states from 2000 to 2015). Second, the first regression might have omitted the variable bias so that the 
P-value of multifetal pregnancy changed when we controlled for prenatal care and tobacco use. Multifetal 
pregnancy substantially increases the risk of preterm birth and infant death (16, 31, 32). In 2013, the IMR 
for twins (24.37) was more than 4 times the rate for single births (5.25) (16). The IMR for triplets (61.08) 
was nearly 12 times, and the rate for quadruplets (137.04) was 26 times the rate for single births. 
However, previous studies (16, 31, 32) did not use a multivariate analysis to disentangle the effects of 
multiple risk factors over time. Our analysis investigates the percentage impact of multifetal birth at the 
state level to examine the factors that might be associated with state variations in infant mortality while 
previous studies compared the IMR between singleton and multifetal births. 
 Cessation of cigarette smoking during pregnancy is recommended because it is a prevalent and 
preventable cause of infant mortality (33-35). It is estimated that 5% of infant mortality and 5.0%–7.3% of 
preterm-related deaths are attributable to maternal smoking (36, 37). Our findings are not consistent with 
these studies, which may be attributed to our different design. Traditional studies of smoking in pregnancy 
have examined cross-sectional data. We assessed the association of the PMR and smoking using cross-
sectional time series data. Notably, between 2000 and 2004 in the U.S., smoking among childbearing age 
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women decreased from 25.5% to 21.7%, while preterm birth rates increased from 11.6% to 12.5% (38). 
One study reported a model for the most important interventions for 39 countries and suggests that 
smoking cessation had the lowest contribution in reducing the rate of preterm deaths (39). 
Our study was limited by the quality of CDC data that may vary by state and hospital over time 
(40). In addition, due to a lack of information, we could not control for some behavioral risk factors (e.g., 
drug abuse prevalence and behavioral factors, such as pregnant women’s adherence to prevention 
programs), which may bias our regression results. 
Overall, some states performed better in terms of reducing their IMRs over the past decade. 
Reducing preterm-related death was the biggest factor in states that have improved their infant deaths. It 
appears that state variations in reducing preterm-related deaths can be partially explained by better 
access to prenatal care, although the impact size is not large. More qualitative and in-depth analyses are 
needed to understand why some states have successfully reduced their preterm-related deaths better 
than others. 
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Appendix	A	 List	of	OMR	Causes	1 
From	wonder.cdc.gov:		2 
1) Location:	The	state,	region	and	division	data	are	derived	from	the	"STRESFIPB"	variable	in	the	public	use	files	for	years	3 
1999-2002,	and	from	"MRSTATEFIPS"	in	the	public	use	files	for	years	2003-2004,	and	from	"MRTERR"	for	years	2005-4 
2015.	The	county	data	are	derived	from	the	combined	values	in	variables	"STRESFIPB"	+	"CNTYRFPB"	in	the	public	use	5 
files	for	years	1999-2002,	and	from	"MRSTATEFIPS"	+	"MRCNTYFIPS"	in	the	public	use	files	for	years	2003-2004,	and	6 
from	"MRTERR"+	"MRCNTY"	for	years	2005-2015.	7 
	8 
2) Gestational	age	at	birth	based	on	Last	Menstrual	Period	(LMP).	9 
3) The	"Gestational	Age	at	Birth"	data	for	years	1995-1998	and	the	"Gestational	Age	10"	(formerly	named	"Gestational	10 
Age	Group2")	data	are	derived	from	the	"GESTAT10"	variable	in	the	public	use	data	for	years	1995-2002,	and	derived	11 
from	the	"GESTREC10"	variable	in	the	public	use	data	for	years	2003	and	later.	12 
	13 
A00-B99	(Certain	infectious	and	parasitic	diseases)	
C00-D48	(Neoplasms)	
D50-D89	(Diseases	of	the	blood	and	blood-forming	organs	and	certain	disorders	involving	the	immune	mechanism)	
E00-E88	(Endocrine,	nutritional	and	metabolic	diseases)	
F01-F99	(Mental	and	behavioural	disorders)	
G00-G98	(Diseases	of	the	nervous	system)	
H00-H57	(Diseases	of	the	eye	and	adnexa)	
H60-H93	(Diseases	of	the	ear	and	mastoid	process)	
I00-I99	(Diseases	of	the	circulatory	system)	
J00-J98	(Diseases	of	the	respiratory	system)	
K00-K14	(Diseases	of	oral	cavity,	salivary	glands	and	jaws)	
K20-K31	(Diseases	of	oesophagus,	stomach	and	duodenum)	
K35-K38	(Diseases	of	appendix)	
K40-K46	(Hernia)	
K50-K52	(Noninfective	enteritis	and	colitis)	
K55.1	(Chronic	vascular	disorders	of	intestine)	
K55.2	(Angiodysplasia	of	colon)	
K55.8	(Other	vascular	disorders	of	intestine)	
K55.9	(Vascular	disorder	of	intestine,	unspecified)	
K56	(Paralytic	ileus	and	intestinal	obstruction	without	hernia)	
K57	(Diverticular	disease	of	intestine)	
K58	(Irritable	bowel	syndrome)	
K59	(Other	functional	intestinal	disorders)	
K60	(Fissure	and	fistula	of	anal	and	rectal	regions)	
K61	(Abscess	of	anal	and	rectal	regions)	
K62	(Other	diseases	of	anus	and	rectum)	
K63	(Other	diseases	of	intestine)	
K65-K66	(Diseases	of	peritoneum)	
K70-K76	(Diseases	of	liver)	
K80-K86	(Disorders	of	gallbladder,	biliary	tract	and	pancreas)	
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K90-K92	(Other	diseases	of	the	digestive	system)	
L00-L98	(Diseases	of	the	skin	and	subcutaneous	tissue)	
M00-M99	(Diseases	of	the	musculoskeletal	system	and	connective	tissue)	
N00-N98	(Diseases	of	the	genitourinary	system)	
O00-O99	(Pregnancy,	childbirth	and	the	puerperium)	
P00	(Newborn	affected	by	maternal	conditions	that	may	be	unrelated	to	present	pregnancy)	
P01.2	(Newborn	affected	by	oligohydramnios)	
P01.3	(Newborn	affected	by	polyhydramnios)	
P01.4	(Newborn	affected	by	ectopic	pregnancy)	
P01.6	(Newborn	affected	by	maternal	death)	
P01.7	(Newborn	affected	by	malpresentation	before	labour)	
P01.8	(Newborn	affected	by	other	maternal	complications	of	pregnancy)	
P01.9	(Newborn	affected	by	maternal	complication	of	pregnancy,	unspecified)	
P02.2	(Newborn	affected	by	other	and	unspecified	morphological	and	functional	abnormalities	of	placenta)	
P02.3	(Newborn	affected	by	placental	transfusion	syndromes)	
P02.4	(Newborn	affected	by	prolapsed	cord)	
P02.5	(Newborn	affected	by	other	compression	of	umbilical	cord)	
P02.6	(Newborn	affected	by	other	and	unspecified	conditions	of	umbilical	cord)	
P02.8	(Newborn	affected	by	other	abnormalities	of	membranes)	
P02.9	(Newborn	affected	by	abnormality	of	membranes,	unspecified)	
P03	(Newborn	affected	by	other	complications	of	labour	and	delivery)	
P04	(Newborn	affected	by	noxious	influences	transmitted	via	placenta	or	breast	milk)	
P05	(Slow	fetal	growth	and	fetal	malnutrition)	
P08	(Disorders	related	to	long	gestation	and	high	birth	weight)	
P10.0	(Subdural	haemorrhage	due	to	birth	injury)	
P10.1	(Cerebral	haemorrhage	due	to	birth	injury)	
P10.3	(Subarachnoid	haemorrhage	due	to	birth	injury)	
P10.4	(Tentorial	tear	due	to	birth	injury)	
P10.8	(Other	intracranial	lacerations	and	haemorrhages	due	to	birth	injury)	
P10.9	(Unspecified	intracranial	laceration	and	haemorrhage	due	to	birth	injury)	
P11	(Other	birth	injuries	to	central	nervous	system)	
P12	(Birth	injury	to	scalp)	
P13	(Birth	injury	to	skeleton)	
P14	(Birth	injury	to	peripheral	nervous	system)	
P15	(Other	birth	injuries)	
P20	(Intrauterine	hypoxia)	
P21	(Birth	asphyxia)	
P23	(Congenital	pneumonia)	
P24	(Neonatal	aspiration	syndromes)	
P25	(Interstitial	emphysema	and	related	conditions	originating	in	the	perinatal	period)	
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P26	(Pulmonary	haemorrhage	originating	in	the	perinatal	period)	
P28.2	(Cyanotic	attacks	of	newborn)	
P28.3	(Primary	sleep	apnoea	of	newborn)	
P28.4	(Other	apnoea	of	newborn)	
P28.5	(Respiratory	failure	of	newborn)	
P28.8	(Other	specified	respiratory	conditions	of	newborn)	
P28.9	(Respiratory	condition	of	newborn,	unspecified)	
P29	(Cardiovascular	disorders	originating	in	the	perinatal	period)	
P35	(Congenital	viral	diseases)	
P37	(Other	congenital	infectious	and	parasitic	diseases)	
P38	(Omphalitis	of	newborn	with	or	without	mild	haemorrhage)	
P39	(Other	infections	specific	to	the	perinatal	period)	
P50	(Fetal	blood	loss)	
P51	(Umbilical	haemorrhage	of	newborn)	
P52.4	(Intracerebral	(nontraumatic)	haemorrhage	of	newborn)	
P52.5	(Subarachnoid	(nontraumatic)	haemorrhage	of	newborn)	
P52.6	(Cerebellar	(nontraumatic)	and	posterior	fossa	haemorrhage	of	newborn)	
P52.8	(Other	intracranial	(nontraumatic)	haemorrhages	of	newborn)	
P52.9	(Intracranial	(nontraumatic)	haemorrhage	of	newborn,	unspecified)	
P53	(Haemorrhagic	disease	of	newborn)	
P54	(Other	neonatal	haemorrhages)	
P55	(Haemolytic	disease	of	newborn)	
P56	(Hydrops	fetalis	due	to	haemolytic	disease)	
P57	(Kernicterus)	
P58	(Neonatal	jaundice	due	to	other	excessive	haemolysis)	
P59	(Neonatal	jaundice	from	other	and	unspecified	causes)	
P60	(Disseminated	intravascular	coagulation	of	newborn)	
P61	(Other	perinatal	haematological	disorders)	
P70-P74	(Transitory	endocrine	and	metabolic	disorders	specific	to	newborn)	
P76	(Other	intestinal	obstruction	of	newborn)	
P78	(Other	perinatal	digestive	system	disorders)	
P80-P83	(Conditions	involving	the	integument	and	temperature	regulation	of	newborn)	
P90-P96	(Other	disorders	originating	in	the	perinatal	period)	
R00-R09	(Symptoms	and	signs	involving	the	circulatory	and	respiratory	systems)	
R10-R19	(Symptoms	and	signs	involving	the	digestive	system	and	abdomen)	
R20-R23	(Symptoms	and	signs	involving	the	skin	and	subcutaneous	tissue)	
R25-R29	(Symptoms	and	signs	involving	the	nervous	and	musculoskeletal	systems)	
R30-R39	(Symptoms	and	signs	involving	the	urinary	system)	
R40-R46	(Symptoms	and	signs	involving	cognition,	perception,	emotional	State	and	behaviour)	
R47-R49	(Symptoms	and	signs	involving	speech	and	voice)	
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R50-R68	(General	symptoms	and	signs)	
R70-R79	(Abnormal	findings	on	examination	of	blood,	without	diagnosis)	
R80-R82	(Abnormal	findings	on	examination	of	urine,	without	diagnosis)	
R83-R89	(Abnormal	findings	on	examination	of	other	body	fluids,	substances	and	tissues,	without	diagnosis)	
R90-R94	(Abnormal	findings	on	diagnostic	imaging	and	in	function	studies,	without	diagnosis)	
R95	(Sudden	infant	death	syndrome)	
R99	(Other	ill-defined	and	unspecified	causes	of	mortality)	
U00-U99	(Codes	for	special	purposes)	
V01-Y89	(External	causes	of	morbidity	and	mortality)	
R96	(Other	sudden	death,	cause	unknown)	
R98	(Unattended	death)	
  14 
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Appendix	B	 Causes	of	Mortality	per	state	15 
Table 4A represents the data for IMR and all four subgroups for each state in 2015. 16 
Table	4A	IMR	and	Subgroups	per	State	17 
No	 State	 IMR	 PMR	 CMR	 SMR	 OMR	
1	 Alabama	 8.31	 2.77	 1.46	 1.07	 3.02	
2	 Alaska	 6.91	 1.86	 1.33	 0.89	 2.84	
3	 Arizona	 5.47	 1.63	 1.34	 0.16	 2.34	
4	 Arkansas	 7.53	 1.85	 1.59	 1.57	 2.49	
5	 California	 4.43	 1.57	 1.12	 0.24	 1.50	
6	 Colorado	 4.66	 1.91	 1.01	
	
1.71	
7	 Connecticut	 5.65	 2.83	 0.56	
	
2.04	
8	 Delaware	 9.22	 4.66	 1.07	
	
3.40	
9	 Florida	 6.24	 2.37	 1.20	 0.28	 2.39	
10	 Georgia	 7.79	 2.91	 1.45	 0.84	 2.58	
11	 Hawaii	 5.70	 2.12	 0.98	
	
2.33	
12	 Idaho	 4.69	 1.01	 1.49	 0.44	 1.75	
13	 Illinois	 6.00	 2.44	 1.11	 0.09	 2.35	
14	 Indiana	 7.31	 2.43	 1.69	 0.40	 2.77	
15	 Iowa	 4.23	 1.04	 1.09	 0.48	 1.62	
16	 Kansas	 5.95	 2.12	 1.46	 0.46	 1.92	
17	 Kentucky	 6.68	 1.79	 1.38	 1.04	 2.50	
18	 Louisiana	 7.56	 2.57	 1.21	 0.70	 3.09	
19	 Maine	 6.58	 2.06	 1.27	
	
2.70	
20	 Maryland	 6.59	 3.10	 1.17	 0.83	 1.49	
21	 Massachusetts	 4.32	 2.20	 0.53	 0.15	 1.43	
22	 Michigan	 6.53	 2.38	 1.34	 0.29	 2.51	
23	 Minnesota	 5.17	 1.86	 1.25	 0.16	 1.90	
24	 Mississippi	 9.45	 3.10	 1.51	 0.47	 4.38	
25	 Missouri	 6.49	 2.08	 1.43	 0.24	 2.73	
26	 Montana	 5.80	 0.95	 1.59	 0.95	 2.30	
27	 Nebraska	 5.70	 1.31	 1.57	 0.82	 1.95	
28	 Nevada	 5.18	 1.29	 1.35	
	
2.42	
29	 New	Hampshire	 4.10	 1.21	
	  
2.41	
30	 New	Jersey	 4.68	 1.60	 0.85	 0.44	 1.80	
31	 New	Mexico	 5.07	 1.01	 1.39	
	
2.60	
32	 New	York	 4.63	 1.64	 0.84	 0.09	 2.06	
33	 North	Carolina	 7.35	 2.92	 1.22	 0.15	 3.05	
34	 North	Dakota	 7.16	 1.77	 1.77	 1.24	 2.39	
 18 
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No	 State	 IMR	 PMR	 CMR	 SMR	 OMR	
35	 Ohio	 7.18	 2.76	 1.32	 0.60	 2.49	
36	 Oklahoma	 7.30	 2.39	 1.54	 0.94	 2.43	
37	 Oregon	 5.15	 1.86	 0.99	 0.50	 1.80	
38	 Pennsylvania	 6.15	 2.55	 1.00	 0.47	 2.14	
39	 Rhode	Island	 5.91	 2.91	
	  
2.00	
40	 South	Carolina	 6.91	 2.53	 1.24	 0.43	 2.72	
41	 South	Dakota	 7.30	 1.78	 1.54	 0.81	 3.16	
42	 Tennessee	 6.94	 1.90	 1.44	 0.24	 3.37	
43	 Texas	 5.71	 1.75	 1.40	 0.42	 2.15	
44	 Utah	 5.02	 1.46	 1.28	 0.45	 1.83	
45	 Vermont	 4.57	
	   
2.37	
46	 Virginia	 5.90	 2.09	 1.25	 0.57	 1.99	
47	 Washington	 4.88	 1.58	 1.24	 0.61	 1.45	
48	 West	Virginia	 7.07	 2.22	 1.57	 0.71	 2.52	
49	 Wisconsin	 5.80	 2.13	 1.21	 0.18	 2.28	
50	 Wyoming	 4.89	 1.67	 1.29	 		 1.80	
 19 
Note that any states with less than 10 deaths in each subgroup is eliminated due to CDC data user 20 
agreement.  21 
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Appendix	C	 ADEQUACY	OF	PRENATAL	CARE:	KESSNER	INDEX	22 
 23 
ADEQUATE*  
 Gestation (weeks)****  Number of Prenatal Visits  
13 or less AND 1 or more or not stated 
14-17 AND 2 or more 
18-21 AND  3 or more  
22-25 AND 4 or more  
26-29 AND  5 or more  
30-31 AND  6 or more  
32-33 AND  7 or more  
34-35 AND  8 or more  
36 or more  AND 9 or more  
	  INADEQUATE**  
 Gestation (weeks)****  Number of Prenatal Visits  
14-21*** AND 0 or not stated 
22-29 AND 1 or less or not stated 
30-31 AND  2 or less or not stated  
32-33 AND 3 or less or not stated  
34 or more AND  4 or less or not stated  
	  INTERMEDIATE: All combinations other than specified above  
  * In addition to the specified number of visits indicated for adequate care, the Interval to the first prenatal  
visit has to be 13 weeks or less (first trimester). 
** In addition to the specified number of visits indicated for inadequate care, all Women who started their  
prenatal care during the third trimester (28 weeks or later) are considered inadequate.  
*** For this gestation group, care is considered inadequate if the time of the first visit is not Stated. 
**** When month and year are specified but day is missing, input 15 for day. Adequacy categories are in  
accord with recommendations of American College of Obstetrics and Gynecology and the World Health 
Organization. 
  24 
Ebrahimvandi	et	al.	
	 25	
Appendix	D	 List	of	missing	values	for	each	value	25 
Tobacco use and prenatal care have many missing values between 2011-2014. California did not report 26 
tobacco use for any year. Therefore, we will remove California in the second regression. Additionally, 27 
Florida, Georgia, and Michigan have incomplete or missing values for prenatal care and smoking. 28 
Therefore, we removed these States as well.  29 
In 2011, 15 areas with “Not Available” data for tobacco use: 30 
Alabama", "Alaska", "Arizona", "Arkansas", "Connecticut", "Hawaii", "Maine", "Massachusetts", 31 
"Michigan", "Minnesota", "Mississippi", "New Jersey", "Rhode Island", "Virginia", "West Virginia" 32 
In 2012, 13 areas with “Not Available” data for tobacco use: "Alabama", "Alaska", "Arizona", "Arkansas", 33 
"Connecticut", "Hawaii", "Maine", "Michigan", "Mississippi", "New Jersey", "Rhode Island", "Virginia", 34 
"West Virginia" 35 
In 2013, 10 areas with “Not Available” data for tobacco use: "Alabama", "Arizona", "Arkansas", 36 
"Connecticut", "Hawaii", "Maine", "Michigan", "New Jersey", "Rhode Island", "West Virginia" 37 
In 2014, 4 areas with “Not Available” data for tobacco use: "Connecticut", "Hawaii", "New Jersey", "Rhode 38 
Island" 39 
In 2015, 2 areas with “Not Available” data for tobacco use: "Connecticut", "New Jersey" 40 
 41 
 42 
 43 
 44 
Figure	3A	Data	on	Preterm-Related	Mortality	and	State-Level	Factors	for	50	U.S.	States 45 
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Appendix	E	 Performance	Analysis	of	full	list	of	States	47 
Without dropping any states from categories, the mean IMR in successful states was 7.53 in 2000 48 
and declined to 5.90 in 2015 (P-Value<0.001), representing 1.63 less deaths per 1,000 live births (Figure 49 
4A). In successful states, reduction in the PMR accounted for the largest reduction in IMR—a 0.76 50 
reduction (P-Value <0.001) from 2.63 to 1.87 (Figure 4A). Forty-seven percent of the IMR reduction (0.76 51 
out of 1.63) in successful states was due to the PMR reduction. The reduction size in the CMR, SMR, and 52 
OMR were 0.32 (from 1.57 to 1.25 with P-Value=0.001), 0.34 (from 0.72 to 0.38 with P-Value<0.001), and 53 
0.20 (2.60 to 2.40 with P-Value=0.086), respectively. 54 
The IMR mean in unsuccessful states was 6.63 in 2000, which then declined by 0.29 per 1,000 55 
live births to 6.34 deaths per 1,000 in 2015 (P-Value=0.051). In unsuccessful states, the PMR slightly 56 
decreased by 0.04 from 2.28 deaths per 1,000 to 2.24 (P-Value=0.60), the CMR declined by 0.12 from 57 
1.37 to 1.25 (P-Value=0.017), the SMR reduced by 0.13 from 0.68 to 0.55 (P-Value=0.069), and the OMR 58 
stayed almost the same by 0.01 decline from 2.30 to 2.29 (P-Value=0.967) (Figure 4A).  59 
The changes in the PMR differed significantly between successful and unsuccessful states (P-60 
Value<0.001). Successful states reduced their PMRs by 0.76, while the other group experienced a slight 61 
decrease in the PMR—0.04— over the period of 2000 to 2015. The reduction for the CMR and SMR was 62 
also significantly different between the two groups of states (P-Values of 0.028 and 0.036, respectively). 63 
Successful states reduced their CMRs by 0.32, which is more than 2.5 times of the reduction size in 64 
unsuccessful states—0.12. The SMR reduction size for successful states was 0.34, which is significantly 65 
larger than the reduction size of unsuccessful states—0.13. Although the OMR size was the largest after 66 
the PMR, its reduction size was not large in any categories of states (0.20 in successful versus 0.01 in 67 
unsuccessful states), this difference was not significant (P-Value=0.172). 68 
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	69 
 70 
Figure	4A	Performances	of	successful	and	unsuccessful	states	in	reduction	of	IMR	and	its	subgroups	in	2000	and	2015	71 
  72 
7.53
2.63
1.57
0.72
2.60
5.90
1.87
1.25
0.38
2.40
6.63
2.28
1.37
0.68
2.30
6.34
2.24
1.25
0.55
2.29
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
IMR PMR CMR SMR OMR
In
fa
nt
 D
ea
th
s 
pe
r 1
00
0 
B
irt
hs
Successful 2000 Successful 2015 Unsuccessful 2000 Unsuccessful 2015
Ebrahimvandi	et	al.	
	 28	
Appendix	F	 Category	of	states	73 
Table	5A	List	of	States	Based	on	Performance	in	Reduction	of	IMR	between	2000	to	2015	74 
Successful States   Unsuccessful States 
 
 States dropped from the 
sample 
state 
Reduction 
Size 
 
state 
Reduction 
Size 
 
state 
Reduction 
Size 
Arizona -1.28 
 
Alaska 0.00 
 
Alabama -1.20 
California -0.99 
 
Arkansas -0.62 
 
Louisiana -1.47 
Colorado -1.49 
 
Connecticut -0.86 
 
Maine 1.73 
Hawaii -2.39 
 
Delaware -0.37 
 
Massachusetts -0.27 
Idaho -2.87 
 
Florida -0.67 
 
Mississippi -1.19 
Illinois -2.49 
 
Georgia -0.66 
 
South Dakota 2.08 
Iowa -2.20 
 
Indiana -0.46 
 
Tennessee -2.13 
Michigan -1.67 
 
Kansas -0.68 
 
Utah -0.24 
Nebraska -1.44 
 
Kentucky -0.42 
 
Washington -0.32 
Nevada -1.34 
 
Maryland -0.93 
   New Hampshire -1.72 
 
Minnesota -0.45 
   New Jersey -1.59 
 
Missouri -0.70 
   New Mexico -1.54 
 
Montana -0.13 
   New York -1.77 
 
Ohio -0.50 
   North Carolina -1.27 
 
Oregon -0.42 
   North Dakota -1.18 
 
Pennsylvania -0.96 
   Oklahoma -1.17 
 
Rhode Island -0.40 
   South Carolina -1.85 
 
Texas 0.09 
   Vermont -1.73 
 
West Virginia -0.36 
   Virginia -1.01 
 
Wisconsin -0.83 
   Wyoming -1.82 
       75 
To make initial average rates of IMR comparable among two groups of successful and unsuccessful 76 
states, we removed states with high initial IMR (IMR at 2000 > 9) from “Successful” and states with low 77 
initial IMR (IMR at 2000 < 5.5) from “Unsuccessful” and repeated the analysis. Therefore, we removed 78 
Alabama, Louisiana, Mississippi, and Tennessee from successful states because of high initial IMR in 79 
2000—9.51, 9.03, 10.64, and 9.07 respectively. Also, we dropped Massachusetts, Maine, South Dakota, 80 
Utah, and Washington with low initial IMR from unsuccessful states— 4.59, 4.85, 5.22, 5.26, and 5.20 81 
respectively (The third column in Table 4).Error! Reference source not found.  82 
 83 
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 84 
Figure	5A	Category	of	state	Based	on	Performance	in	Reduction	of	IMR	between	2000	and	2015	85 
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